CC - Chemours Co (CC) Q1 2024 Earnings Call Transcript
2024-05-01 11:09:04 ET
Chemours Co (CC)
Q1 2024 Results Conference Call
May 1, 2024 08:00 AM ET
Company Participants
Brandon Ontjes - Vice President of Investor Relations
Denise Dignam - President and Chief Executive Officer
Matt Abbott - Chief Financial Officer
Conference Call Participants
Duffy Fischer - Goldman Sachs
John McNulty - BMO Capital Markets
Josh Spector - UBS Financial
Hassan Ahmed - Alembic Global Advisors
Mike Leithead - Barclays
Turner Hinrichs - Morgan Stanley
Presentation
Operator
Good morning. My name is Lovely, and I will be your conference operator today. I would like to welcome everyone to The Chemours Company First Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the conclusion of the prepared remarks. I would like to remind everyone that this conference call is being recorded.
I would now like to hand the conference call over to Brandon Ontjes, Vice President of Investor Relations for Chemours. You may now begin your conference.
Brandon Ontjes
Good morning, everybody. Welcome to the Chemours Company's first quarter 2024 earnings conference call. I’m joined today by Denise Dignam, President and Chief Executive Officer; and our Interim Chief Financial Officer, Matt Abbott.
Before we start, I'd like to remind you that comments made on this call, as well as in the supplemental information provided in our presentation and on our website, contain forward-looking statements that involve risks and uncertainties, as described in Chemours' SEC filings. These forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events that may not be realized.
Actual results may differ, and Chemours undertakes no duty to update any forward-looking statements as a result of future developments or new information. During the course of this call, we will refer to certain non-GAAP financial measures that we believe are useful to investors evaluating the company's performance. A reconciliation of non-GAAP terms and adjustments are included in our release issued yesterday. Also, we posted our earnings presentation to our website last evening.
With that, I will turn the call over to Denise Dignam.
Denise Dignam
Thank you, Brandon, and good morning, everyone.
I'm going to start this morning by talking about our overall performance and dive more deeply into TT. Then I'm going to turn the call over to Matt to cover our segment level performance as well as our balance sheet and liquidity position. I'll then provide our outlook for the second quarter and spend some time on TSS, because I received a lot of questions from many of you on this business during our recent meetings. We'll then close with your questions....
Chemours Co (CC) Q1 2024 Earnings Call Transcript